Biomedical Data Science
Showing 1-16 of 16 Results
-
Corinne Beck
Administrative Program Manager - Plevritis Lab, Biomedical Data Science
Current Role at StanfordProgram Manager
Plevritis Lab
Department of Biomedical Data Science (DBDS)
School of Medicine | Stanford University -
Vasiliki (Vicky) Bikia
Postdoctoral Scholar, Biomedical Data Sciences
BioDr. Vasiliki Bikia is a Postdoctoral Researcher at Stanford University, jointly affiliated with the Institute for Human-Centered Artificial Intelligence (HAI) and the Department of Biomedical Data Science, where she works under the mentorship of Prof. Roxana Daneshjou. She holds an Advanced Diploma in Electrical and Computer Engineering from the Aristotle University of Thessaloniki (AUTH), Greece (2017), and a Ph.D. in Biomedical Engineering from the Swiss Federal Institute of Technology of Lausanne (EPFL), Switzerland (2021). Her doctoral work focused on addressing the clinical need for non-invasive cardiovascular monitoring by combining machine learning with physics-based numerical modeling.
Dr. Bikia's research centers on the development of large multimodal models to improve patient outcome prediction. She is also passionate about building patient-facing chatbots that help individuals better understand complex medical information, ultimately aiming to enhance communication and empower patients in their care journey. Moreover, she has contributed to the Stanford Spezi framework, designing and prototyping the Spezi Data Pipeline tool for enhanced digital health data accessibility and analysis workflows. -
Daniel Bloch
Professor (Research) of Biomedical Data Science (BDS), Emeritus
BioI received my PhD. in Mathematical Statistics in 1967. I joined the research community at the Stanford University School of Medicine, Division of Immunology & Rheumatology, in 1984 as head statistician directing the biostatistics consulting and analytic support of the Arthritis Rheumatism Aging Medical Information System (ARAMIS) and Multipurpose Arthritis Center (MAC) grant-related research programs. In 1993 I was appointed Associate Professor with a joint appointment in the Departments of Medicine and of Health Research & Policy, and am currently Professor of Biostatistics at Stanford University, emeritus since 2007. My contributions to the statistics literature span numerous fields, including methods of sample size estimation, efficiency and bias of estimators, research methods for kappa statistics, non-parametric classification methods and methods of assessing multi-parameter endpoints. I have over 200 peer-reviewed publications. I have been directly involved with the development of numerous criteria rules for classification of diseases and with establishing guidelines for clinical trial research and in proposing responder criteria for osteoarthritis drugs. Since 1987, I have been a consultant on an ad hoc basis to pharmaceutical and biotechnical firms, including both start-up and established companies. I have extensive experience with devices, drugs and biologics and have participated in all aspects of applying statistics to implement investigational plans; e.g.: for protocol development, design of trials, database design. I’ve been a member of the FDA Statistical Advisors Panel, the statistical member on numerous data safety monitoring boards, and frequently represent companies at meetings with the FDA
-
Pauline Brochet
Postdoctoral Scholar, Biomedical Informatics
BioPauline Brochet is a French scientist from Souraide, France. She completed her undergraduate studies in Molecular, Cellular and Physiological Biology (BSc, Université Clermont-Auvergne) and earned a Master's degree in Software Development and Data Analysis (MSc, Aix-Marseille Université). Pauline pursued a PhD at TAGC (Theories and Approaches for Genomic Complexity) in Marseille, France.
Under the supervision of Dr. Christophe Chevillard and Dr. Lionel Spinelli, Pauline integrated multi-omics data from human heart tissue to investigate the pathogenic processes associated with Chagas Disease Cardiomyopathy (CCC). Notably, she contributed to the development of ChagasDB, the first database associating key features with the different stages of Chagas disease. Her research identified the involvement of mitochondrial DNA mutations, non-coding RNA, transcription factors, and DNA methylation in various pathogenic processes, all leading to the progression of CCC.
Currently, at Stanford University, under the guidance of Dr. Matthew Wheeler and Dr. Daniel Katz, Pauline is conducting postdoctoral research on multi-omics data analysis as part of the Molecular Transducers of Physical Activity Consortium (MoTrPAC). Her work focuses on identifying key covariable features associated with physical exercise, with the ultimate goal of discovering exercise-mimetic drugs that could help prevent heart diseases.
